The IPO window is reopening—but liquidity is the real test

The U.S. IPO market is moving from a scarcity story to a supply-and-absorption story. Recent deal flow, a deep fall pipeline and a more complicated liquidity backdrop suggest that the next phase will not be judged only by how many companies list, but by whether public markets can absorb new shares without weakening execution quality.

That matters for the growth-and-demand hypothesis around DDOG, SNOW, RH, WSM, ETH, LZB, LESL and TPX. Resilient demand can support earnings, but the market’s capacity to finance and trade that growth is a separate variable.

The issuance window has widened

Recent market trackers point to a notably active 2026. Renaissance Capital’s fall preview said U.S. IPOs had raised $146 billion year to date as of September 8, including $71 billion excluding SpaceX, while describing a pipeline led by large AI-related names and other sectors.^[1] A separate September 18 weekly recap reported three IPOs and two SPACs priced during the week, alongside five IPO and three SPAC filings; it also noted that a potential Nscale offering could be multibillion-dollar.^[2]

The calendar is not a promise of completed supply. The same week’s reporting showed that Holtec Nuclear postponed its proposed IPO, a reminder that filing activity and priced issuance are different stages of the process.^[2] Reuters also reported new U.S. IPO filings from Retension Pharmaceuticals and TRex Bio, reinforcing that biotech remains part of the autumn pipeline.^[2]

Working interpretation: the market is open enough to attract issuers, but selective enough that price discovery, timing and aftermarket performance still matter more than the headline filing count.

Why liquidity deserves equal billing

A larger primary market can improve access to capital and broaden the public-company universe. It can also increase the amount of stock that dealers, exchanges and investors must process. Liquidnet’s Q3 2026 liquidity report described a contradiction: record trading volumes alongside thinner displayed depth, wider spreads, smaller trade sizes and greater execution complexity.^[3]

That is a market-structure issue, not a call on any one company. A high-volume market is not automatically a deep market. If displayed depth falls faster than activity rises, a moderate order can move price more than the turnover headline implies. For newly listed companies, that can amplify first-week volatility, complicate institutional entry and make lockup expirations more consequential.

The plumbing is also changing. The SEC has proposed amendments to Regulation NMS covering trade-through and locked-or-crossed markets.^[4] The SEC’s 2026 materials also show continuing implementation and temporary relief around minimum pricing increments, access fees and better-priced orders.^[4] These changes do not determine whether an IPO succeeds, but they can affect displayed liquidity, routing economics and the way fragmented markets interact.

![A financial-district skyline represents the capital-market network that must absorb new equity supply.]

The issuance-versus-buyback balance

For much of the last two decades, companies buying back more stock than they issued helped reduce listed-equity supply. Pictet describes that period as “de-equitisation” and argues that markets may be moving toward “re-equitisation,” in which issuance becomes a more important source of supply.^[3]

The distinction matters for the companies in scope:

This is why earnings resilience and market plumbing should be tracked together. A company can report healthy demand and still face a difficult equity-market setup if supply arrives faster than liquidity or if volatility raises the cost of holding the stock.

What the current scope can—and cannot—show

The current evidence supports a conditional version of the hypothesis, not a blanket conclusion. The IPO pipeline indicates that issuers see a workable capital-raising window. The liquidity data warn that execution conditions may be less robust than volume alone suggests. The earnings schedule also gives the next set of checkpoints: DDOG is currently listed for an estimated November 5 report before the open; SNOW for an estimated December 2 report after the close; RH for an estimated December 10 report after the close; WSM for an estimated November 18 report before the open; LZB for an estimated November 17 report after the close; and LESL for an estimated December 1 report after the close. TPX has no confirmed date in the current calendar.^[5]

Those dates are monitoring points, not forecasts. The core test is whether management commentary and reported numbers show durable demand without requiring ever-easier financing conditions.

A practical checklist for the next leg

What to watch next

1. Whether the fall pipeline converts into priced deals. Watch for the gap between filings, marketed ranges, postponements and completed offerings. The important signal is not simply a busy calendar; it is repeated access at credible terms.
2. Aftermarket behavior in new listings. Track spreads, turnover, price impact and the persistence of first-week moves rather than treating the opening print as a verdict.
3. Lockup and secondary supply. A strong IPO cohort can create its own future supply overhang when early investors and insiders become eligible to sell. Calendar data should be checked against actual float and trading depth.
4. The buyback offset. If repurchases remain large enough to absorb issuance, the net supply picture is different than gross IPO proceeds imply. If buybacks retreat while issuance accelerates, the market faces a more direct absorption test.
5. The next earnings checkpoints. DDOG, SNOW, RH, WSM, LZB and LESL have scheduled but estimated dates in the current calendar, while TPX has no confirmed date.^[5] For the full scope, look for evidence that demand is broadening rather than merely benefiting from easier comparisons or temporary inventory effects.
6. Market-structure implementation. SEC and exchange actions on tick sizes, access fees, odd lots, trade-through protections and listing standards can alter the quality of displayed liquidity even when the macro narrative is unchanged.^[4]

The balanced base case is that a healthier IPO window can coexist with resilient operating demand—but only if the market can absorb new supply without a lasting deterioration in depth and execution. The bear case is not “no demand.” It is demand that proves real at the company level while public-market supply, volatility and financing conditions become less forgiving. That distinction is the central market-structure question for the next year.